Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Taconic teams with Medicyte in marketing agreement
October 2013
SHARING OPTIONS:

HUDSON, N.Y.Taconic, a supplier of genetically modified rat and mouse models and services, and Medicyte announced a marketing and sales agreement in early September under which Taconic will promote and sell Medicyte-developed human primary upcyte hepatocyte cell strains and related media for in-vitro applications. This agreement will strengthen Taconic's tADMET portfolio of models and improve Medicyte's product distribution and market visibility.  
 
"Human hepatocytes are indispensable for many applications in research, drug screening and development. However, the availability of primary human hepatocytes is limited and their quality is variable," said Joris Braspenning, managing director for Medicyte, in a press release about the deal. "With the upcyte Hepatocytes, we can bring predictive, reliable and standardized cells on the market to close that gap."  
 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.